Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer

Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer

BackgroundNon–small cell lung cancer (NSCLC) has entered the era of immunotherapy. However, only partial patients were able to benefit from immune checkpoint inhibitors (ICIs). Currently, biomarkers for predicting patients’ response to ICIs are primarily tumor tissue dependent and have limited accur...

Full description

Bibliographic Details
Main Authors: Kang Miao, Xiaotong Zhang, Hanping Wang, Xiaoyan Si, Jun Ni, Wei Zhong, Jing Zhao, Yan Xu, Minjiang Chen, Ruili Pan, Mengzhao Wang, Li Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Immunology
Subjects:
immune checkpoint inhibitors (ICIs)
lymphocyte subsets
CD4+CD45RA− T cell
biomarker
CD8+CD38+ T cell
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.912180/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.912180/full

Similar Items